Literature DB >> 9789161

Psychiatric comorbidity in methadone maintained patients.

B J Mason1, J H Kocsis, D Melia, E T Khuri, J Sweeney, A Wells, L Borg, R B Millman, M J Kreek.   

Abstract

Diagnosing comorbid psychiatric disorders in methadone maintained patients may help to identify subgroups with different outcomes and needs for treatment. In this study, 75 methadone maintenance clinic patients in treatment longer than 30 days were assessed with the Addiction Severity Index, Global Assessment Scale and Mini-Mental Status Exam, and were interviewed for DSM-III-R psychiatric diagnosis using the computerized Diagnostic Interview Schedule. Psychiatric diagnoses were prevalent in the sample with depression, phobic disorders, antisocial personality and generalized anxiety the most common. Both number of DSM-III-R diagnoses and severity of psychopathology were correlated with outcome measures such as concurrent drug abuse, family-social problems and employment status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789161     DOI: 10.1300/J069v17n03_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  21 in total

1.  Managing Hepatitis C in Users of Illicit Drugs.

Authors:  Brian R Edlin; Michael R Carden; Stephen J Ferrando
Journal:  Curr Hepat Rep       Date:  2007

2.  Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States.

Authors:  Marcus A Bachhuber; William N Southern; Chinazo O Cunningham
Journal:  Med Care       Date:  2014-05       Impact factor: 2.983

3.  Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus.

Authors:  J W Lunden; L G Kirby
Journal:  Neuroscience       Date:  2013-09-20       Impact factor: 3.590

4.  Chronic pain and opioid abuse: Factors associated with health-related quality of life.

Authors:  Jermaine D Jones; Jonathan S Vogelman; Rachel Luba; Mudassir Mumtaz; Sandra D Comer
Journal:  Am J Addict       Date:  2017-11-21

Review 5.  κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Authors:  Eduardo R Butelman; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

6.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

7.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

Review 8.  Recent advances in the treatment of opiate addiction.

Authors:  Paul J Fudala; George W Woody
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

9.  Influence of Psychiatric and Personality Disorders on Smoking Cessation Among Individuals in Opiate Dependence Treatment.

Authors:  Nina A Cooperman; Shou-En Lu; Kimber P Richter; Steven L Bernstein; Jill M Williams
Journal:  J Dual Diagn       Date:  2016-04-11

10.  The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD.

Authors:  Carl Latkin; Melissa Davey-Rothwell; Jing-yan Yang; Natalie Crawford
Journal:  J Urban Health       Date:  2013-02       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.